Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan

Chung Hsin Chen, Hung Yi Chiou, Yu Mei Hsueh, Chien Jen Chen, Hong Jeng Yu, Yeong Shiau Pu

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose: We compared clinicopathological characteristics and outcomes in patients with bladder cancer who were exposed to graded arsenic levels in drinking water. Materials and Methods: From 1993 through 2006, 977 patients with bladder cancer in Taiwan were studied retrospectively. Patients were from 3 areas, including the core zone (arsenic related blackfoot disease endemic area with a well water arsenic level of 350 to 1,100 ng/ml), zone 1 (a well water arsenic level of 350 ng/ml or greater but not a blackfoot disease endemic area) and zone 2 (a well water arsenic level of less than 350 ng/ml). Clinicopathological characteristics and survival outcome were compared among the groups. Results: Of these patients 81 (8.3%), 246 (25.2%) and 650 (66.5%) lived in the core zone, and zones 1 and 2, respectively. More high grade and high stage tumors were observed in core zone patients than in those in zones 1 and 2, including high grade in 48.7% vs 41.4% and 39.2% of patients, advanced disease in 39.5% vs 31.0% and 18.5% and nodal metastasis in 8.6% vs 3.3% and 3.4%, respectively. Median overall and cancer specific survival in core zone patients was significantly shorter than in patients in zones 1 and 2, including 69 vs 119 and 113-month overall survival and for the 75th percentile of cancer specific survival 34.5 vs 119 and 113 months, respectively. On multivariate analysis with adjustment for tumor grade and stage the zonal difference was not a significant factor for overall or cancer specific survival. Conclusions: Patients with arsenic related bladder cancer may have decreased overall and cancer specific survival because they have more unfavorable tumor phenotypes than patients in other areas in Taiwan.

Original languageEnglish
Pages (from-to)547-553
Number of pages7
JournalJournal of Urology
Volume181
Issue number2
DOIs
Publication statusPublished - Feb 2009
Externally publishedYes

Fingerprint

Arsenic
Taiwan
Urinary Bladder Neoplasms
Survival
Neoplasms
Endemic Diseases
Water
Drinking Water
Multivariate Analysis
Neoplasm Metastasis
Phenotype

Keywords

  • arsenic poisoning
  • carcinoma
  • Taiwan
  • transitional cell
  • urinary bladder
  • water

ASJC Scopus subject areas

  • Urology

Cite this

Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan. / Chen, Chung Hsin; Chiou, Hung Yi; Hsueh, Yu Mei; Chen, Chien Jen; Yu, Hong Jeng; Pu, Yeong Shiau.

In: Journal of Urology, Vol. 181, No. 2, 02.2009, p. 547-553.

Research output: Contribution to journalArticle

Chen, Chung Hsin ; Chiou, Hung Yi ; Hsueh, Yu Mei ; Chen, Chien Jen ; Yu, Hong Jeng ; Pu, Yeong Shiau. / Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan. In: Journal of Urology. 2009 ; Vol. 181, No. 2. pp. 547-553.
@article{30c119bf4cc5443591696aaf01f3b225,
title = "Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan",
abstract = "Purpose: We compared clinicopathological characteristics and outcomes in patients with bladder cancer who were exposed to graded arsenic levels in drinking water. Materials and Methods: From 1993 through 2006, 977 patients with bladder cancer in Taiwan were studied retrospectively. Patients were from 3 areas, including the core zone (arsenic related blackfoot disease endemic area with a well water arsenic level of 350 to 1,100 ng/ml), zone 1 (a well water arsenic level of 350 ng/ml or greater but not a blackfoot disease endemic area) and zone 2 (a well water arsenic level of less than 350 ng/ml). Clinicopathological characteristics and survival outcome were compared among the groups. Results: Of these patients 81 (8.3{\%}), 246 (25.2{\%}) and 650 (66.5{\%}) lived in the core zone, and zones 1 and 2, respectively. More high grade and high stage tumors were observed in core zone patients than in those in zones 1 and 2, including high grade in 48.7{\%} vs 41.4{\%} and 39.2{\%} of patients, advanced disease in 39.5{\%} vs 31.0{\%} and 18.5{\%} and nodal metastasis in 8.6{\%} vs 3.3{\%} and 3.4{\%}, respectively. Median overall and cancer specific survival in core zone patients was significantly shorter than in patients in zones 1 and 2, including 69 vs 119 and 113-month overall survival and for the 75th percentile of cancer specific survival 34.5 vs 119 and 113 months, respectively. On multivariate analysis with adjustment for tumor grade and stage the zonal difference was not a significant factor for overall or cancer specific survival. Conclusions: Patients with arsenic related bladder cancer may have decreased overall and cancer specific survival because they have more unfavorable tumor phenotypes than patients in other areas in Taiwan.",
keywords = "arsenic poisoning, carcinoma, Taiwan, transitional cell, urinary bladder, water, arsenic poisoning, carcinoma, transitional cell, urinary bladder, water",
author = "Chen, {Chung Hsin} and Chiou, {Hung Yi} and Hsueh, {Yu Mei} and Chen, {Chien Jen} and Yu, {Hong Jeng} and Pu, {Yeong Shiau}",
year = "2009",
month = "2",
doi = "10.1016/j.juro.2008.10.003",
language = "English",
volume = "181",
pages = "547--553",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan

AU - Chen, Chung Hsin

AU - Chiou, Hung Yi

AU - Hsueh, Yu Mei

AU - Chen, Chien Jen

AU - Yu, Hong Jeng

AU - Pu, Yeong Shiau

PY - 2009/2

Y1 - 2009/2

N2 - Purpose: We compared clinicopathological characteristics and outcomes in patients with bladder cancer who were exposed to graded arsenic levels in drinking water. Materials and Methods: From 1993 through 2006, 977 patients with bladder cancer in Taiwan were studied retrospectively. Patients were from 3 areas, including the core zone (arsenic related blackfoot disease endemic area with a well water arsenic level of 350 to 1,100 ng/ml), zone 1 (a well water arsenic level of 350 ng/ml or greater but not a blackfoot disease endemic area) and zone 2 (a well water arsenic level of less than 350 ng/ml). Clinicopathological characteristics and survival outcome were compared among the groups. Results: Of these patients 81 (8.3%), 246 (25.2%) and 650 (66.5%) lived in the core zone, and zones 1 and 2, respectively. More high grade and high stage tumors were observed in core zone patients than in those in zones 1 and 2, including high grade in 48.7% vs 41.4% and 39.2% of patients, advanced disease in 39.5% vs 31.0% and 18.5% and nodal metastasis in 8.6% vs 3.3% and 3.4%, respectively. Median overall and cancer specific survival in core zone patients was significantly shorter than in patients in zones 1 and 2, including 69 vs 119 and 113-month overall survival and for the 75th percentile of cancer specific survival 34.5 vs 119 and 113 months, respectively. On multivariate analysis with adjustment for tumor grade and stage the zonal difference was not a significant factor for overall or cancer specific survival. Conclusions: Patients with arsenic related bladder cancer may have decreased overall and cancer specific survival because they have more unfavorable tumor phenotypes than patients in other areas in Taiwan.

AB - Purpose: We compared clinicopathological characteristics and outcomes in patients with bladder cancer who were exposed to graded arsenic levels in drinking water. Materials and Methods: From 1993 through 2006, 977 patients with bladder cancer in Taiwan were studied retrospectively. Patients were from 3 areas, including the core zone (arsenic related blackfoot disease endemic area with a well water arsenic level of 350 to 1,100 ng/ml), zone 1 (a well water arsenic level of 350 ng/ml or greater but not a blackfoot disease endemic area) and zone 2 (a well water arsenic level of less than 350 ng/ml). Clinicopathological characteristics and survival outcome were compared among the groups. Results: Of these patients 81 (8.3%), 246 (25.2%) and 650 (66.5%) lived in the core zone, and zones 1 and 2, respectively. More high grade and high stage tumors were observed in core zone patients than in those in zones 1 and 2, including high grade in 48.7% vs 41.4% and 39.2% of patients, advanced disease in 39.5% vs 31.0% and 18.5% and nodal metastasis in 8.6% vs 3.3% and 3.4%, respectively. Median overall and cancer specific survival in core zone patients was significantly shorter than in patients in zones 1 and 2, including 69 vs 119 and 113-month overall survival and for the 75th percentile of cancer specific survival 34.5 vs 119 and 113 months, respectively. On multivariate analysis with adjustment for tumor grade and stage the zonal difference was not a significant factor for overall or cancer specific survival. Conclusions: Patients with arsenic related bladder cancer may have decreased overall and cancer specific survival because they have more unfavorable tumor phenotypes than patients in other areas in Taiwan.

KW - arsenic poisoning

KW - carcinoma

KW - Taiwan

KW - transitional cell

KW - urinary bladder

KW - water

KW - arsenic poisoning

KW - carcinoma

KW - transitional cell

KW - urinary bladder

KW - water

UR - http://www.scopus.com/inward/record.url?scp=58149316200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149316200&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2008.10.003

DO - 10.1016/j.juro.2008.10.003

M3 - Article

VL - 181

SP - 547

EP - 553

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -